Abstract: Provided herein is a means for increasing protein retention in blood. The protein retention in blood is increased by forming a conjugate of a protein and chondroitin produced by a microorganism having chondroitin-producing capability and/or chondroitin synthesized with a chondroitin synthase.

Abstract: Provided herein is a means for increasing protein retention in blood. The protein retention in blood is increased by forming a conjugate of a protein and chondroitin produced by a microorganism having chondroitin-producing capability and/or chondroitin synthesized with a chondroitin synthase.

Abstract: The present invention provides a method of screening an agent for the prevention/treatment of cancer. More specifically, the present invention provides a screening method/screening kit for screening a compound or its salt that changes the binding properties of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or salts thereof, to a ligand capable of binding specifically to the protein, which comprises using (a) the protein, its partial peptides, or salts thereof and (b) the ligand capable of binding specifically to the protein; compounds obtained by the screening or salts thereof; agents for the prevention/treatment of cancer comprising the compounds or salts thereof; and so on.

Abstract: The present invention intends to provide a novel peptide and use thereof. More particularly, the present invention provides a novel peptide and a DNA encoding the same, a drug comprising the peptide or DNA, a screening method/screening kit for a compound or its salt that promotes or inhibits the activity of the peptide, a compound or its salt obtained by the screening, a drug comprising the compound or its salt, etc. The peptide of the invention and the DNA encoding the same are usable, e.g., for the diagnosis, treatment, prevention, etc. of digestive diseases, etc. Moreover, the peptide of the invention is useful as a reagent for screening a compound or its salt that promotes or inhibits the activity of the protein of the invention.

Abstract: The present invention provides a method of screening an agent for the prevention/treatment of cancer. More specifically, the present invention provides a screening method/screening kit for screening a compound or its salt that changes the binding properties of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or salts thereof, to a ligand capable of binding specifically to the protein, which comprises using (a) the protein, its partial peptides, or salts thereof and (b) the ligand capable of binding specifically to the protein; compounds obtained by the screening or salts thereof; agents for the prevention/treatment of cancer comprising the compounds or salts thereof; and so on.

Abstract: The present invention intends to provide a novel peptide and use thereof. More particularly, the present invention provides a novel peptide and a DNA encoding the same, a drug comprising the peptide or DNA, a screening method/screening kit for a compound or its salt that promotes or inhibits the activity of the peptide, a compound or its salt obtained by the screening, a drug comprising the compound or its salt, etc. The peptide of the invention and the DNA encoding the same are usable, e.g., for the diagnosis, treatment, prevention, etc. of digestive diseases, etc. Moreover, the peptide of the invention is useful as a reagent for screening a compound or its salt that promotes or inhibits the activity of the protein of the invention.

Abstract: The present invention intends to provide a novel peptide and use thereof. More particularly, the present invention provides a novel peptide and a DNA encoding the same, a drug comprising the peptide or DNA, a screening method/screening kit for a compound or its salt that promotes or inhibits the activity of the peptide, a compound or its salt obtained by the screening, a drug comprising the compound or its salt, etc. The peptide of the invention and the DNA encoding the same are usable, e.g., for the diagnosis, treatment, prevention, etc. of digestive diseases, etc. Moreover, the peptide of the invention is useful as a reagent for screening a compound or its salt that promotes or inhibits the activity of the protein of the invention.

Abstract: The present invention provides a method of screening a compound or its salt promoting or inhibiting the activity of a novel protein, etc; a screening kit therefor; compounds or salt thereof obtained by the screening; drugs containing these compounds or salts thereof; and so on. These drugs are usable as, for example, angiogenesis, inhibitors in prevention /remedies for cancer, ovary diseases, inflammatory diseases, diabetic retinopathy, etc.

Abstract: The present invention intends to provide a novel peptide and use thereof. More particularly, the present invention provides a novel peptide and a DNA encoding the same, a drug comprising the peptide or DNA, a screening method/screening kit for a compound or its salt that promotes or inhibits the activity of the peptide, a compound or its salt obtained by the screening, a drug comprising the compound or its salt, etc.

Abstract: The present invention provides a novel peptide, a DNA encoding the same, etc. These peptide and DNA are usable in screening a compound that alters the binding properties between the peptide and a receptor protein to which the peptide can bind. The above peptide, a compound obtained by the above screening method, etc. are usable, for example, for the treatment and prevention of digestive diseases, etc.

Abstract: The present invention is intended to provide therapeutic/prophylactic agents and diagnostic for digestive diseases, etc.

Abstract: A white display layer 3 for forming a display part 2 of scales, characters and numerals is provided on the front side of a light transmitting substrate 1, and a black opaque layer 4 is formed by printing on a position except the display part 2. A transparent protective layer 5A is provided to cover the display part 2 and the opaque layer 4. Transparent and colorless beads are oriented in the protective layer 5A on the front side. Therefore, the surface of the display panel has a state of fine unevenness.